3D echocardiography has improved our understanding of mitral valve pathology and selection of appropriate therapy.
Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...
3D echocardiography has improved our understanding of mitral valve pathology and selection of appropriate therapy.